June 30, 2026 · Form 4 insider transaction
Espinoza Octavio bought 17 shares of Ligand Pharmaceuticals Incorporated at $160.71 per share, a transaction worth $2.7K. The trade was recorded as j and disclosed on an SEC Form 4, filed 6 days after the transaction.
These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).